Walking Ability and Limit of Stability in Children With Spastic Cerebral Palsy

November 29, 2022 updated by: Bayram Sırrı, Muş Alparlan University

an Investigation of the Relationship Between Walking Ability and Limit of Stability in Children With Spastic Cerebral Palsy

Trunk control in children with spastic Cerebral Palsy (CP) is impaired. They have weaker trunk muscle strenght, and insufficient sitting/standing balance according to their developing peers. Since their weak trunk muscles and insufficient balance responses, they are not able to walk as functional similar to their peers. Additionaly limit of stability is worsen in children with CP. Investigation of the relationship between walking ability and limit of stability when seated position is important to understand which child is acceptable for training of walk. However we did not found any study to explain it. Therefore the aim of this study is to investigate walking ability and limit of stability in children with spastic CP, and to compare their developing peers.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

20

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Ankara
      • Altındağ, Ankara, Turkey
        • Recruiting
        • Hacettepe University
        • Principal Investigator:
          • Semra Topuz, Prof.
        • Sub-Investigator:
          • Gökhan Karakaş, MSc
        • Sub-Investigator:
          • Alev Doğan, MSc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

4 years to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Spastic cerebral palsy and their developing peers

Description

Inclusion Criteria:

  • spastic serebral palsy, between the ages 6-15 years, between the I-IV. levels of GMFCS, be able to understand command given by physical therapist

Exclusion Criteria:

  • undergone botulinum toxin A to upper and/or lower extremities, undergone any surgery to their extremities, be at the V. levels of GMFCS

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Spastic Cerebral Palsy
Children with spastic cerebral palsy
Other: GAITRite gaitway system, Bertec Balance System
GAITRite gaitway system will use to assess gait parameters, Bertec Balance System will use to assess limit of stability
Healthy Developing Peers
Children with healthy developing peers
Other: GAITRite gaitway system, Bertec Balance System
GAITRite gaitway system will use to assess gait parameters, Bertec Balance System will use to assess limit of stability

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gait parameters (stride length in cm, step width in cm, time in swing phase in second, time in stance phase in second)
Time Frame: 20 minutes
Gait parameters will be assessed by GAITRite walking way system.
20 minutes
Limit of stability when sitting and standing position in cm
Time Frame: 20 minutes
Limit of stability will be evaluated by BERTEC balance system.
20 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Muş Alparlan University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 29, 2022

Primary Completion (Anticipated)

June 1, 2023

Study Completion (Anticipated)

June 1, 2024

Study Registration Dates

First Submitted

October 7, 2022

First Submitted That Met QC Criteria

October 13, 2022

First Posted (Actual)

October 18, 2022

Study Record Updates

Last Update Posted (Actual)

December 2, 2022

Last Update Submitted That Met QC Criteria

November 29, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • GO-22/398

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gait, Spastic

Clinical Trials on GAITRite gaitway system, Bertec Balance System

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe